Skip to main content

Drug Interactions

  • Chapter
  • First Online:
Cardiac Drug Therapy

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 3398 Accesses

Abstract

Several cardiac drugs manifest some form of interaction with each other or with noncardiac drugs. It is of paramount importance for the physician to be aware of these interactions, which may be potentially harmful to patients or may negate salutary effects. In addition, the prescribing physician must be conscious of these interactions so as to avoid errors that may provoke medicolegal action.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Baker WP, Dainer P, Lester WM, et al. Ischemic chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol. 1986;57:497.

    Article  CAS  PubMed  Google Scholar 

  • Becker RC, Caputo R, Ball S, et al. Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration. Am Heart J. 1993;126:11.

    Article  CAS  PubMed  Google Scholar 

  • Belmonte MA, Cequiere A, Roig-Escofet D. Severe ventricular arrhythmia after methylprednisolone pulse therapy in rheumatoid arthritis. J Rheumatol. 1986;13:477.

    CAS  PubMed  Google Scholar 

  • Blum CB. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Am J Cardiol. 1994;73:3D.

    Article  CAS  PubMed  Google Scholar 

  • Brown DL, Sather S, Cheitlin MD. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J. 1993;125:1439.

    Article  CAS  PubMed  Google Scholar 

  • Buff DD, Brenner R, Kirtane SS, Gilboa R. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry. 1991;52:174.

    CAS  PubMed  Google Scholar 

  • Cheng TO. Interaction of herbal drugs with digoxin. J Am Coll Cardiol. 2002;40:838.

    Article  PubMed  Google Scholar 

  • Ellison JM, Milofsky JE, Ely E. Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry. 1990;51:385.

    CAS  PubMed  Google Scholar 

  • Esselink RAJ, Gerding MN, Brouwers PJAM, et al. Total heart block after intravenous metoclopramide. Lancet. 1994;343:182.

    Article  Google Scholar 

  • Feder R. Bradycardia and syncope induced by fluoxetine. J Clin Psychiatry. 1991;52:139.

    CAS  PubMed  Google Scholar 

  • Glassman AH, Roose SP, Bigger JT. The safety of tricyclic antidepressants in cardiac patients. JAMA. 1993;269:2673.

    Article  CAS  PubMed  Google Scholar 

  • Gore JM, Sloan M, Price TR, and the TIMI Investigators, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction study. Circulation. 1991;83:448.

    Article  CAS  PubMed  Google Scholar 

  • Hobl E, Stimlfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects. A randomized double—blind placebo-controlled trial. J Am Coll Cardiol. 2014;63(7):630–5.

    Article  CAS  PubMed  Google Scholar 

  • Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713–8.

    Article  PubMed Central  PubMed  Google Scholar 

  • Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808.

    Article  CAS  PubMed  Google Scholar 

  • Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of non-antiarrhythmic drugs. Am Heart J. 1993;126:201.

    Article  CAS  PubMed  Google Scholar 

  • Nosten F, terKuile FO, Luxemburger C. Cardiac effects of anti-malarial treatment with halofantrine. Lancet. 1993;341:1054.

    Article  CAS  PubMed  Google Scholar 

  • Ochs HR, Carstens G, Greenblatt DJ. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med. 1980;303:373.

    Article  CAS  PubMed  Google Scholar 

  • Ottervanger JP, Paalman HJA, Boxma GL, et al. Transmural myocardial infarction with sumatriptan. Lancet. 1993;341:861.

    Article  CAS  PubMed  Google Scholar 

  • Simons FER, Simons KJ, Wood AJJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med. 1994;330:1663.

    Article  CAS  PubMed  Google Scholar 

  • Trohman RG, Estes DM, Castellanos A, et al. Increased quinidine plasma concentration during administration of verapamil: a new quinidine-verapamil interaction. Am J Cardiol. 1986;57:706.

    Article  CAS  PubMed  Google Scholar 

  • Zipes DP. Unwitting exposure to risk. Cardiol Rev. 1993;1:1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Khan, M.G. (2015). Drug Interactions. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-962-4_21

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-961-7

  • Online ISBN: 978-1-61779-962-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics